Israel: 13% bệnh nhân COVID-19 nhập viện có triệu chứng thần kinh nặng

Trong số hơn 16.000 bệnh nhân mắc COVID-19 nhập viện tại Israel, có tới 13% phát triển các triệu chứng thần kinh nghiêm trọng, phổ biến nhất là bệnh não.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Mỹ ký hợp đồng 22,9 tỷ USD tăng sản xuất tên lửa Tomahawk

Mỹ ký hợp đồng 22,9 tỷ USD tăng sản xuất tên lửa Tomahawk

Thế giới
(Baothanhhoa.vn) - Bộ Quốc phòng Mỹ vừa cho biết, Hải quân nước này đã trao cho tập đoàn quốc phòng Raytheon hợp đồng trị giá 22,9 tỷ USD nhằm mở rộng và đẩy nhanh sản xuất tên lửa hành trình Tomahawk, trong bối cảnh Washington quan ngại về khả năng bổ sung kho vũ khí...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh